SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing treatments for serious hematological diseases, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference taking place January 11-14, 2016 at the Westin St. Francis Hotel in San Francisco, California. David J. Bearss, Chief Executive Officer, is scheduled to present at 10:30 a.m. PST on Wednesday, January 13, 2016.
